Fox (FOX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive
FOX Zacks Investment Research — October 14, 2025Fox (FOX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Fiverr (FVRR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? — Positive
FVRR Zacks Investment Research — October 14, 2025Fiverr (FVRR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a Bet — Positive
DAWN Zacks Investment Research — October 14, 2025The mean of analysts' price targets for Day One Biopharmaceuticals (DAWN) points to a 241.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Byrna Technologies (BYRN) Have the Potential to Rally 65.23% as Wall Street Analysts Expect? — Positive
BYRN Zacks Investment Research — October 14, 2025The consensus price target hints at a 65.2% upside potential for Byrna Technologies (BYRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know — Positive
DRIO Zacks Investment Research — October 14, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in DarioHealth (DRIO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know — Positive
SEM Zacks Investment Research — October 14, 2025The mean of analysts' price targets for Select Medical (SEM) points to a 36.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here's Why Bank of Marin (BMRC) Looks Ripe for Bottom Fishing — Neutral
BMRC Zacks Investment Research — October 14, 2025After losing some value lately, a hammer chart pattern has been formed for Bank of Marin (BMRC), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Wall Street Analysts Believe Mobileye (MBLY) Could Rally 25.86%: Here's is How to Trade — Positive
MBLY Zacks Investment Research — October 14, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 25.9% in Mobileye (MBLY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Predict a 30.28% Upside in Kodiak Gas (KGS): Here's What You Should Know — Positive
KGS Zacks Investment Research — October 14, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 30.3% in Kodiak Gas (KGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect? — Positive
KMDA Zacks Investment Research — October 14, 2025The mean of analysts' price targets for Kamada (KMDA) points to an 114.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet — Positive
KNSA Zacks Investment Research — October 14, 2025The mean of analysts' price targets for Kiniksa Pharmaceuticals International, plc (KNSA) points to a 29.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to Trade — Positive
RLAY Zacks Investment Research — October 14, 2025The mean of analysts' price targets for Relay Therapeutics (RLAY) points to an 116.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
JPMorgan says the stock is a buy. It's about more than construction machinery.
Walmart said on Tuesday it was partnering with OpenAI to enable customers and Sam's Club members to shop directly within ChatGPT, using the AI chatbot's Instant Checkout feature.
VOYA Stock Trading at a Discount to Industry at 1.12X: Time to Buy? — Positive
VOYA Zacks Investment Research — October 14, 2025Voya Financial is well-positioned for sustainable earnings growth, disciplined capital deployment and enhanced shareholder value, aided by strong operational execution.
Why Ambarella (AMBA) is a Top Momentum Stock for the Long-Term — Positive
AMBA Zacks Investment Research — October 14, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Affiliated Managers Group (AMG) is a Top Momentum Stock for the Long-Term — Positive
AMG Zacks Investment Research — October 14, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock — Positive
ALNY Zacks Investment Research — October 14, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term — Positive
IRWD Zacks Investment Research — October 14, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why BankUnited, Inc. (BKU) is a Top Momentum Stock for the Long-Term — Positive
BKU Zacks Investment Research — October 14, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.